Using Telemedicine to Assist in the Clinical Care of Patients With Decompensated Cirrhosis

NCT07439770 | Not Yet Recruiting

• 1 other identifier: 202410060RINC
• Study Type: interventional
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn if an integrated digital and telemedicine care model works to manage decompensated cirrhosis in patients. It will also learn about the impact of this model on healthcare resource consumption and patient quality of life. The main questions it aims to answer are:

1. 1.Does this telemedicine model lower the number of cirrhosis-related hospitalizations and emergency department visits?
2. 2.Does the model reduce medical expenses and improve disease outcomes compared to standard care?
3. 3.Use the NTUH telehealth platform (NTUH-TPC) to access records and upload physiological, medical, and imaging data.
4. 4.Wear a smart watch for remote physiological monitoring. Receive continuous remote care and proactive follow-ups from case managers.

Conditions

Decompensated Cirrhosis of Liver

Keywords

decompensated cirrhosis; telemedicine; digital medicine; mobile health; prognosis; health care

Outcome Measures

Primary Outcomes (1)

• Change in Liver Disease Severity Scores

  MELD 3.0 score

  12 months

Secondary Outcomes (6)

• Rate of All-Cause Unplanned Hospitalizations

  12 months

• Rate of All-Cause Unplanned Emergency Room Visits

  12 months

• Days alive and out of hospital

  12 months

• Quality of Life Score & Patient Satisfaction

  12 months

• Feasibility and Adherence to telemedicine

  12 months

Study Arms (2)

Telemedicine care

EXPERIMENTAL

Telemedice care platform

Device: Telemedicine care

Starndard Helath Care

NO INTERVENTION

Standard health care

Interventions

Telemedicine care DEVICE

1. NTUH telehealth platform for cirrhosis, NTUH-TPC 2. Provide a wearable device (Asus vivowatch 6 aero) 3. Telemonitoring by case manager 4. Self-reported information from enrolled patients

Telemedicine care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with decompensated cirrhosis and a Child score of B or C
• Age: 18 years or older
• Must return for a follow-up visit at least every 3 months

You may not qualify if:

• Patients with active malignant tumors (those with a history of malignant tumors must have been cured for at least 2 years)
• Patients with an expected survival of less than one year

Sponsors & Collaborators

• National Taiwan University Hospital: lead
• National Science and Technology Council, Taiwan: collaborator

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Central Study Contacts

Tung Hung Su, MD, PhD

CONTACT

886-972651694; tunghungsu@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 1, 2026
• First Posted: February 27, 2026
• Study Start: February 23, 2026
• Primary Completion (Estimated): December 31, 2028
• Study Completion (Estimated): December 31, 2028
• Last Updated: February 27, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)